Clinical trial
Combination Chemotherapy Followed by Bone Marrow or Peripheral Stem Cell…
NCT00002549 · European Organisation for Research and Treatment of Cancer - EORTC, Other · Unknown status
Key facts
| NCT number | NCT00002549 |
|---|---|
| Title | Combination Chemotherapy Followed by Bone Marrow or Peripheral Stem Cell Transplantation in Treating Patients With Acute Myelogenous Leukemia |
| Official title | RANDOMIZED PHASE III STUDY OF INDUCTION (ICE VS MICE VS DCE) AND INTENSIVE CONSOLIDATION (IDIA VS NOVIA VS DIA) FOLLOWED BY BONE MARROW TRANSPLANTATION IN ACUTE MYELOGENOUS LEUKEMIA: AML 10 PROTOCOL |
| Lead sponsor | European Organisation for Research and Treatment of Cancer - EORTC, Other |
| Status | Unknown status |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Leukemia |
| Intervention type | Biological, Drug, Procedure, Radiation |
| Interventions | filgrastim, busulfan, cyclophosphamide, cytarabine, daunorubicin hydrochloride, etoposide, idarubicin, mesna, mitoxantrone hydrochloride, allogeneic bone marrow transplantation and 3 more |
| Enrollment | 1,520 |
| Start date | Nov 1, 1993 |
| First posted | Jul 19, 2004 |
| Last update posted | Dec 23, 2009 |
| Countries | Austria, Belgium, Croatia, Czechia, France, Germany, Hungary, Italy, Netherlands, Portugal, Turkey (Türkiye) |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: